Evan Kelly, MD
Surgery · Crosby, MNNPI 1124478458
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $10,469 of the $12,719 with a category attached, or 82.3%. It is spread thinly across 13 manufacturers, the largest accounting for just 19.2%. Reporting peaked in 2024 at $4,473 and has fallen 81.0% since, to $850 in 2025.
Across 66 payments — averaging $192.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apollo Endosurgery US Inc$2K
- Boston Scientific$2K
- TELA Bio, Inc.$2K
- Globus Medical$2K
- Northern X-ray Company$1K
- W. L. Gore & Associates, Inc.$1K
- plus $2K from 7 others
What the payments were for
- Travel & lodging$10,46982%
- Food & beverage$2,25118%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apollo Endosurgery US Inc | 11 | $2,437 |
| Boston Scientific | 14 | $2,132 |
| TELA Bio, Inc. | 3 | $1,694 |
| Globus Medical | 14 | $1,539 |
| Northern X-ray Company | 4 | $1,450 |
| W. L. Gore & Associates, Inc. | 8 | $1,168 |
| Medtronic | 5 | $887 |
| Stryker | 1 | $781 |
| Philips North America LLC | 1 | $475 |
| Lumendi LLC | 1 | $79 |
| AbbVie | 2 | $47 |
| Mauna Kea Technologies, Inc. | 1 | $18 |
| Teleflex LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- X-Tack Endoscopic HeliX Tacking System$2,427
- OverStitch Endoscopic Suturing System$2,054
- OviTex 2S$1,681
- APOLLO ESG System$1,450
- INTERVENTIONAL ANGIOGRAPHY SYSTEM$1,404
- OverStitch Endoscopic Suturing System Sx$1,213
- SPY-PHI SYSTEM$781
- GORE BIO-A Tissue Reinforcement$751
- (6321) Azurion 7 B20 DS Adv$475
- ALIF$347
- GORE SYNECOR Biomaterial$193
- Apollo ESG NXT System$161
- GI Genius$132
- MaXcess$119
- SPYGLASS$113
- WallFlex Duodenal$106
How this compares
$12,719 in reported general payments places this provider in the 85th percentile of 498 surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 12 | $712 |
| Omeprazole | 37 | $509 |
Paid to pharmacies, not to this prescriber.
Other surgery in Crosby
- Andrew LoveittCrosby$87K
- Howard McCollisterCrosby$50K
- Paul SeversonCrosby$23K
- Jayson DockShakopee$266K
- Charles SvendsenMinneapolis$266K
- Michael MegalyMinneapolis$168K
- Andrew SurmakSaint Louis Park$167K
- William NorthrupWhite Bear Lake$160K
- Jolene SinghSt Cloud$150K
- Mark SneiderSaint Paul$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.